Concepedia

Hamidreza Kafi

HK

Statistics

Publications

3

Citations

79

H-Index

3

Active since

2022

Affiliations

Vaxine (Australia)(Current)

Hamidreza Kafi is an author at Vaxine (Australia) specializing in vaccine safety, adjuvant effects on efficacy, and immunology.

Publications per year

2022–2024

3

Publications

3

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari et al. · Clinical Microbiology and Infection · 2022 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration

Reza Karkhaneh, Hooshang Faghihi, Hamid Riazi‐Esfahani et al. · Ophthalmology Retina · 2024 · 19 citations

Medicine, Ophthalmology, Pharmacotherapy +10

Ability of <scp>SpikoGen</scp>®, an <scp>Advax‐CpG</scp> adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against <scp>SARS‐CoV</scp>‐2 variants

Yoshikazu Honda‐Okubo, Anna Antipov, Greiciely O. André et al. · Immunology · 2023 · 12 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–3 of 3